Your browser doesn't support javascript.
loading
FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention.
Humphrey, Jack; Birsa, Nicol; Milioto, Carmelo; McLaughlin, Martha; Ule, Agnieszka M; Robaldo, David; Eberle, Andrea B; Kräuchi, Rahel; Bentham, Matthew; Brown, Anna-Leigh; Jarvis, Seth; Bodo, Cristian; Garone, Maria G; Devoy, Anny; Soraru, Gianni; Rosa, Alessandro; Bozzoni, Irene; Fisher, Elizabeth M C; Mühlemann, Oliver; Schiavo, Giampietro; Ruepp, Marc-David; Isaacs, Adrian M; Plagnol, Vincent; Fratta, Pietro.
Afiliación
  • Humphrey J; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Birsa N; UK Dementia Research Institute.
  • Milioto C; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • McLaughlin M; UCL Genetics Institute, University College London, London WC1E 6BT, UK.
  • Ule AM; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Robaldo D; UK Dementia Research Institute.
  • Eberle AB; UK Dementia Research Institute.
  • Kräuchi R; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Bentham M; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Brown AL; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Jarvis S; UK Dementia Research Institute.
  • Bodo C; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Garone MG; Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, Bern 3012, Switzerland.
  • Devoy A; Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, Bern 3012, Switzerland.
  • Soraru G; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Rosa A; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Bozzoni I; UCL Genetics Institute, University College London, London WC1E 6BT, UK.
  • Fisher EMC; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Mühlemann O; UK Dementia Research Institute.
  • Schiavo G; UCL Genetics Institute, University College London, London WC1E 6BT, UK.
  • Ruepp MD; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Isaacs AM; Sapienza University of Rome, Rome 00185, Italy.
  • Plagnol V; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Fratta P; UK Dementia Research Institute.
Nucleic Acids Res ; 48(12): 6889-6905, 2020 07 09.
Article en En | MEDLINE | ID: mdl-32479602
ABSTRACT
Mutations in the RNA-binding protein FUS cause amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease. FUS plays a role in numerous aspects of RNA metabolism, including mRNA splicing. However, the impact of ALS-causative mutations on splicing has not been fully characterized, as most disease models have been based on overexpressing mutant FUS, which will alter RNA processing due to FUS autoregulation. We and others have recently created knockin models that overcome the overexpression problem, and have generated high depth RNA-sequencing on FUS mutants in parallel to FUS knockout, allowing us to compare mutation-induced changes to genuine loss of function. We find that FUS-ALS mutations induce a widespread loss of function on expression and splicing. Specifically, we find that mutant FUS directly alters intron retention levels in RNA-binding proteins. Moreover, we identify an intron retention event in FUS itself that is associated with its autoregulation. Altered FUS levels have been linked to disease, and we show here that this novel autoregulation mechanism is altered by FUS mutations. Crucially, we also observe this phenomenon in other genetic forms of ALS, including those caused by TDP-43, VCP and SOD1 mutations, supporting the concept that multiple ALS genes interact in a regulatory network.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína FUS de Unión a ARN / Homeostasis / Esclerosis Amiotrófica Lateral Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nucleic Acids Res Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína FUS de Unión a ARN / Homeostasis / Esclerosis Amiotrófica Lateral Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nucleic Acids Res Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido